FDA Inspection 1192781 — CSL Plasma, Inc.
The FDA completed an inspection of CSL Plasma, Inc. on December 8, 2022 in Medford, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Medford, OR (United States)